Oxamine 50mg Tablet (Amoxapine 50mg)

What is Oxamine 50mg Tablet (Amoxapine 50mg)?

Oxamine 50mg Tablet contains amoxapine, a tricyclic antidepressant (TCA) used primarily in the treatment of major depressive disorder. It works by affecting the balance of neurotransmitters like norepinephrine and serotonin in the brain, helping to restore mental equilibrium and reduce symptoms of depression such as low mood, sleep disturbances, and lack of interest in daily activities. This medication requires a valid prescription and should be taken exactly as directed by a licensed healthcare provider.

Key features

• Active Ingredient — Contains 50mg amoxapine per tablet for consistent dosing.
• Antidepressant Class — Belongs to tricyclic antidepressants with norepinephrine reuptake inhibition.
• Prescription-Based — Requires medical supervision for safe use and dosage adjustment.
• Oral Administration — Tablet form ensures ease of intake and bioavailability.
• Mood Stabilization — Helps manage symptoms of depression and related emotional disorders.
• Established Pharmacology — Long-standing use in psychiatric treatment with documented efficacy.

Who is Oxamine 50mg Tablet (Amoxapine 50mg) for?

This medication is intended for individuals diagnosed with major depressive disorder under the guidance of a healthcare professional. It may be prescribed when other antidepressants are ineffective. Not recommended for children, adolescents, or patients with a history of seizures, heart conditions, or bipolar disorder without thorough evaluation. Elderly patients should use with caution due to increased sensitivity.

How does Oxamine 50mg Tablet (Amoxapine 50mg) compare?

Compared to newer antidepressants like SSRIs, Oxamine offers stronger norepinephrine effects but carries a higher risk of side effects such as sedation, dry mouth, and cardiac issues. It may be more effective for treatment-resistant depression but requires closer monitoring than selective serotonin reuptake inhibitors. Unlike atypical antipsychotics, it lacks direct dopamine blockade but has some secondary antipsychotic activity due to metabolites. It's less commonly used as a first-line agent today but remains valuable in specific clinical scenarios.